Intrinsic and acquired resistance mechanisms in enterococcus

References

• Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3:46 - 65; PMID: 2404568
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al, National Healthcare Safety Network Team, Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996 - 1011; http://dx.doi.org/10.1086/591861; PMID: 18947320
   PubMed Web of Science ®Google Scholar
• Rice LB, Lakticová V, Helfand MS, Hutton-Thomas R. In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci. J Infect Dis 2004; 190:2162 - 6; http://dx.doi.org/10.1086/425580; PMID: 15551215
   PubMed Web of Science ®Google Scholar
• Sava IG, Heikens E, Huebner J. Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 2010; 16:533 - 40; http://dx.doi.org/10.1111/j.1469-0691.2010.03213.x; PMID: 20569264
   PubMed Web of Science ®Google Scholar
• Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol Rev 2008; 32:361 - 85; http://dx.doi.org/10.1111/j.1574-6976.2007.00095.x; PMID: 18248419
   PubMed Web of Science ®Google Scholar
• Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130:797 - 810; http://dx.doi.org/10.1016/j.cell.2007.06.049; PMID: 17803904
   PubMed Web of Science ®Google Scholar
• Sifaoui F, Arthur M, Rice L, Gutmann L. Role of penicillin-binding protein 5 in expression of ampicillin resistance and peptidoglycan structure in Enterococcus faecium. Antimicrob Agents Chemother 2001; 45:2594 - 7; http://dx.doi.org/10.1128/AAC.45.9.2594-2597.2001; PMID: 11502534
   PubMed Web of Science ®Google Scholar
• Murray BE. Beta-lactamase-producing enterococci. Antimicrob Agents Chemother 1992; 36:2355 - 9; PMID: 1489177
   PubMed Web of Science ®Google Scholar
• Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, De Girolami PC, Ferraro MJ, et al. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991; 35:2180 - 4; PMID: 1803989
   PubMed Web of Science ®Google Scholar
• Galloway-Peña JR, Nallapareddy SR, Arias CA, Eliopoulos GM, Murray BE. Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. J Infect Dis 2009; 200:1566 - 73; http://dx.doi.org/10.1086/644790; PMID: 19821720
   PubMed Web of Science ®Google Scholar
• Galloway-Peña JR, Rice LB, Murray BE. Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time. Antimicrob Agents Chemother 2011; 55:3272 - 7; http://dx.doi.org/10.1128/AAC.00099-11; PMID: 21576454
   PubMed Web of Science ®Google Scholar
• Fontana R, Aldegheri M, Ligozzi M, Lopez H, Sucari A, Satta G. Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1994; 38:1980 - 3; PMID: 7811006
   PubMed Web of Science ®Google Scholar
• Jawetz E, Sonne M. Penicillin-streptomycin treatment of enterococcal endocarditis. A re-evaluation. N Engl J Med 1966; 274:710 - 5; http://dx.doi.org/10.1056/NEJM196603312741304; PMID: 5908873
   PubMed Web of Science ®Google Scholar
• Bizzini A, Zhao C, Auffray Y, Hartke A. The Enterococcus faecalis superoxide dismutase is essential for its tolerance to vancomycin and penicillin. J Antimicrob Chemother 2009; 64:1196 - 202; http://dx.doi.org/10.1093/jac/dkp369; PMID: 19828491
   PubMed Web of Science ®Google Scholar
• Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 2010; 8:423 - 35; http://dx.doi.org/10.1038/nrmicro2333; PMID: 20440275
   PubMed Web of Science ®Google Scholar
• Krogstad DJ, Pargwette AR. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother 1980; 17:965 - 8; PMID: 6902640
   PubMed Web of Science ®Google Scholar
• Hodges TL, Zighelboim-Daum S, Eliopoulos GM, Wennersten C, Moellering RC Jr.. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother 1992; 36:121 - 5; PMID: 1590676
   PubMed Web of Science ®Google Scholar
• Zimmermann RA, Moellering RC Jr., Weinberg AN. Mechanism of resistance to antibiotic synergism in enterococci. J Bacteriol 1971; 105:873 - 9; PMID: 4994038
   PubMed Web of Science ®Google Scholar
• Moellering RC Jr., Weinberg AN. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest 1971; 50:2580 - 4; http://dx.doi.org/10.1172/JCI106758; PMID: 5001959
   PubMed Web of Science ®Google Scholar
• Geraci JE, Martin WJ. Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases. Circulation 1954; 10:173 - 94; http://dx.doi.org/10.1161/01.CIR.10.2.173; PMID: 13182750
   PubMed Web of Science ®Google Scholar
• Costa Y, Galimand M, Leclercq R, Duval J, Courvalin P. Characterization of the chromosomal aac(6′)-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother 1993; 37:1896 - 903; PMID: 8239603
   PubMed Web of Science ®Google Scholar
• Galimand M, Schmitt E, Panvert M, Desmolaize B, Douthwaite S, Mechulam Y, et al. Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM. RNA 2011; 17:251 - 62; http://dx.doi.org/10.1261/rna.2233511; PMID: 21159796
   PubMed Web of Science ®Google Scholar
• Arias CA, Contreras GA, Murray BE. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 2010; 16:555 - 62; http://dx.doi.org/10.1111/j.1469-0691.2010.03214.x; PMID: 20569266
   PubMed Web of Science ®Google Scholar
• Singh KV, Weinstock GM, Murray BE. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother 2002; 46:1845 - 50; http://dx.doi.org/10.1128/AAC.46.6.1845-1850.2002; PMID: 12019099
   PubMed Web of Science ®Google Scholar
• Portillo A, Ruiz-Larrea F, Zarazaga M, Alonso A, Martinez JL, Torres C. Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother 2000; 44:967 - 71; http://dx.doi.org/10.1128/AAC.44.4.967-971.2000; PMID: 10722498
   PubMed Web of Science ®Google Scholar
• Bushby SR, Hitchings GH. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother 1968; 33:72 - 90; PMID: 5301731
   PubMed Web of Science ®Google Scholar
• Zervos MJ, Schaberg DR. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob Agents Chemother 1985; 28:446 - 8; PMID: 3935044
   PubMed Web of Science ®Google Scholar
• Grayson ML, Thauvin-Eliopoulos C, Eliopoulos GM, Yao JD, DeAngelis DV, Walton L, et al. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1990; 34:1792 - 4; PMID: 2126691
   PubMed Web of Science ®Google Scholar
• Chenoweth CE, Robinson KA, Schaberg DR. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother 1990; 34:1800 - 2; PMID: 2126692
   PubMed Web of Science ®Google Scholar
• Palmer KL, Kos VN, Gilmore MS. Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol 2010; 13:632 - 9; http://dx.doi.org/10.1016/j.mib.2010.08.004; PMID: 20837397
   PubMed Web of Science ®Google Scholar
• Hegstad K, Mikalsen T, Coque TM, Werner G, Sundsfjord A. Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin microbiol infect 2010; 16:541 - 54; http://dx.doi.org/10.1111/j.1469-0691.2010.03226.x; PMID: 20569265
   PubMed Web of Science ®Google Scholar
• Wardal E, Sadowy E, Hryniewicz W. Complex nature of enterococcal pheromone-responsive plasmids. Polish J Microbiol 2010; 59:79 87
   Google Scholar
• Périchon B, Courvalin P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53:4580 - 7; http://dx.doi.org/10.1128/AAC.00346-09; PMID: 19506057
   PubMed Web of Science ®Google Scholar
• Rice LB. Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob Agents Chemother 1998; 42:1871 - 7; PMID: 9687377
   PubMed Web of Science ®Google Scholar
• Murray BE, Mederski-Samaroj B. Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1983; 72:1168 - 71; http://dx.doi.org/10.1172/JCI111042; PMID: 6411768
   PubMed Web of Science ®Google Scholar
• Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist 1996; 2:209 - 13; http://dx.doi.org/10.1089/mdr.1996.2.209; PMID: 9158761
   PubMed Web of Science ®Google Scholar
• Rice LB, Bellais S, Carias LL, Hutton-Thomas R, Bonomo RA, Caspers P, et al. Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother 2004; 48:3028 - 32; http://dx.doi.org/10.1128/AAC.48.8.3028-3032.2004; PMID: 15273117
   PubMed Web of Science ®Google Scholar
• Ono S, Muratani T, Matsumoto T. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Antimicrob Agents Chemother 2005; 49:2954 - 8; http://dx.doi.org/10.1128/AAC.49.7.2954-2958.2005; PMID: 15980374
   PubMed Web of Science ®Google Scholar
• Rice LB, Carias LL, Rudin S, Lakticová V, Wood A, Hutton-Thomas R. Enterococcus faecium low-affinity pbp5 is a transferable determinant. Antimicrob Agents Chemother 2005; 49:5007 - 12; http://dx.doi.org/10.1128/AAC.49.12.5007-5012.2005; PMID: 16304165
   PubMed Web of Science ®Google Scholar
• Clark C, McGhee P, Appelbaum PC, Kosowska-Shick K. Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria. Antimicrob Agents Chemother 2011; 55:2344 - 51; http://dx.doi.org/10.1128/AAC.01602-10; PMID: 21343467
   PubMed Web of Science ®Google Scholar
• Arias CA, Singh KV, Panesso D, Murray BE. Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model. J Antimicrob Chemother 2007; 60:594 - 8; http://dx.doi.org/10.1093/jac/dkm237; PMID: 17606481
   PubMed Web of Science ®Google Scholar
• Arias CA, Singh KV, Panesso D, Murray BE. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates. Antimicrob Agents Chemother 2007; 51:2043 - 7; http://dx.doi.org/10.1128/AAC.00131-07; PMID: 17438057
   PubMed Web of Science ®Google Scholar
• Lascols C, Legrand P, Mérens A, Leclercq R, Muller-Serieys C, Drugeon HB, et al. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints. Int J Antimicrob Agents 2011; 37:235 - 9; http://dx.doi.org/10.1016/j.ijantimicag.2010.11.035; PMID: 21295447
   PubMed Web of Science ®Google Scholar
• Henry X, Amoroso A, Coyette J, Joris B. Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium. Antimicrob Agents Chemother 2010; 54:953 - 5; http://dx.doi.org/10.1128/AAC.00983-09; PMID: 19917749
   PubMed Web of Science ®Google Scholar
• Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis 1983; 147:751 - 7; http://dx.doi.org/10.1093/infdis/147.4.751; PMID: 6404994
   PubMed Web of Science ®Google Scholar
• Ferretti JJ, Gilmore KS, Courvalin P. Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2″-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol 1986; 167:631 - 8; PMID: 3015884
   PubMed Web of Science ®Google Scholar
• Courvalin P, Carlier C, Collatz E. Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J Bacteriol 1980; 143:541 - 51; PMID: 6259117
   PubMed Web of Science ®Google Scholar
• Chow JW. Aminoglycoside resistance in enterococci. Clin Infect Dis 2000; 31:586 - 9; http://dx.doi.org/10.1086/313949; PMID: 10987725
   PubMed Web of Science ®Google Scholar
• Chow JW, Zervos MJ, Lerner SA, Thal LA, Donabedian SM, Jaworski DD, et al. A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother 1997; 41:511 - 4; PMID: 9055984
   PubMed Web of Science ®Google Scholar
• Mahbub Alam M, Kobayashi N, Ishino M, Sumi A, Kobayashi K, Uehara N, et al. Detection of a novel aph(2″) allele (aph[2″]-Ie) conferring high-level gentamicin resistance and a spectinomycin resistance gene ant(9)-Ia (aad 9) in clinical isolates of enterococci. Microb Drug Resist 2005; 11:239 - 47; http://dx.doi.org/10.1089/mdr.2005.11.239; PMID: 16201926
   PubMed Web of Science ®Google Scholar
• Tsai SF, Zervos MJ, Clewell DB, Donabedian SM, Sahm DF, Chow JW. A new high-level gentamicin resistance gene, aph(2″)-Id, in Enterococcus spp. Antimicrob Agents Chemother 1998; 42:1229 - 32; PMID: 9593155
   PubMed Web of Science ®Google Scholar
• Hollingshead S, Vapnek D. Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase. Plasmid 1985; 13:17 - 30; http://dx.doi.org/10.1016/0147-619X(85)90052-6; PMID: 2986186
   PubMed Web of Science ®Google Scholar
• Eliopoulos GM, Farber BF, Murray BE, Wennersten C, Moellering RC Jr.. Ribosomal resistance of clinical enterococcal to streptomycin isolates. Antimicrob Agents Chemother 1984; 25:398 - 9; PMID: 6326668
   PubMed Web of Science ®Google Scholar
• Trieu-Cuot P, Courvalin P. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3′5″-aminoglycoside phosphotransferase type III. Gene 1983; 23:331 - 41; http://dx.doi.org/10.1016/0378-1119(83)90022-7; PMID: 6313476
   PubMed Web of Science ®Google Scholar
• Carlier C, Courvalin P. Emergence of 4′,4″-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob Agents Chemother 1990; 34:1565 - 9; PMID: 2171424
   PubMed Web of Science ®Google Scholar
• Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN. LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States. Antimicrob Agents Chemother 2011; 55:3684 - 90; http://dx.doi.org/10.1128/AAC.01729-10; PMID: 21670176
   PubMed Web of Science ®Google Scholar
• Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37:1563 - 71; PMID: 8215264
   PubMed Web of Science ®Google Scholar
• Gold HS. Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis 2001; 33:210 - 9; http://dx.doi.org/10.1086/321815; PMID: 11418881
   PubMed Web of Science ®Google Scholar
• Reynolds PE, Depardieu F, Dutka-Malen S, Arthur M, Courvalin P. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol Microbiol 1994; 13:1065 - 70; http://dx.doi.org/10.1111/j.1365-2958.1994.tb00497.x; PMID: 7854121
   PubMed Web of Science ®Google Scholar
• Reynolds PE, Arias CA, Courvalin P. Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol 1999; 34:341 - 9; http://dx.doi.org/10.1046/j.1365-2958.1999.01604.x; PMID: 10564477
   PubMed Web of Science ®Google Scholar
• Arthur M, Depardieu F, Molinas C, Reynolds P, Courvalin P. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995; 154:87 - 92; http://dx.doi.org/10.1016/0378-1119(94)00851-I; PMID: 7867956
   PubMed Web of Science ®Google Scholar
• Ribeiro T, Santos S, Marques MI, Gilmore M, de Fátima Silva Lopes M. Identification of a new gene, vanV, in vanB operons of Enterococcus faecalis. Int J Antimicrob Agents 2011; 37:554 - 7; http://dx.doi.org/10.1016/j.ijantimicag.2011.01.024; PMID: 21482081
   PubMed Web of Science ®Google Scholar
• Arthur M, Molinas C, Courvalin P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1992; 174:2582 - 91; PMID: 1556077
   PubMed Web of Science ®Google Scholar
• Gagnon S, Lévesque S, Lefebvre B, Bourgault AM, Labbé AC, Roger M. vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546. J Antimicrob Chemother 2011; 66:2758 - 62; http://dx.doi.org/10.1093/jac/dkr379; PMID: 21926081
   PubMed Web of Science ®Google Scholar
• Choi HJ, Nam D, Peck KR, Song JH, Shin D, Ko KS. Loss of vancomycin resistance not completely dependent on the Tn1546 element in Enterococcus faecium isolates. Diagn Microbiol Infect Dis 2011; 69:105 - 10; http://dx.doi.org/10.1016/j.diagmicrobio.2010.08.030; PMID: 21146722
   PubMed Web of Science ®Google Scholar
• Fines M, Perichon B, Reynolds P, Sahm DF, Courvalin P. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 1999; 43:2161 - 4; PMID: 10471558
   PubMed Web of Science ®Google Scholar
• Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, et al. D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 2011; 55:4606 - 12; http://dx.doi.org/10.1128/AAC.00714-11; PMID: 21807981
   PubMed Web of Science ®Google Scholar
• McKessar SJ, Berry AM, Bell JM, Turnidge JD, Paton JC. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother 2000; 44:3224 - 8; http://dx.doi.org/10.1128/AAC.44.11.3224-3228.2000; PMID: 11036060
   PubMed Web of Science ®Google Scholar
• Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, et al. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 2010; 54:4643 - 7; http://dx.doi.org/10.1128/AAC.01710-09; PMID: 20733041
   PubMed Web of Science ®Google Scholar
• Werner G, Freitas AR, Coque TM, Sollid JE, Lester C, Hammerum AM, et al. Host range of enterococcal vanA plasmids among Gram-positive intestinal bacteria. J Antimicrob Chemother 2011; 66:273 - 82; http://dx.doi.org/10.1093/jac/dkq455; PMID: 21131318
   PubMed Web of Science ®Google Scholar
• Foucault ML, Courvalin P, Grillot-Courvalin C. Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53:2354 - 9; http://dx.doi.org/10.1128/AAC.01702-08; PMID: 19332680
   PubMed Web of Science ®Google Scholar
• Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003; 302:1569 - 71; http://dx.doi.org/10.1126/science.1090956; PMID: 14645850
   PubMed Web of Science ®Google Scholar
• de Niederhäusern S, Bondi M, Messi P, Iseppi R, Sabia C, Manicardi G, et al. Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus. Curr Microbiol 2011; 62:1363 - 7; http://dx.doi.org/10.1007/s00284-011-9868-6; PMID: 21234755
   PubMed Web of Science ®Google Scholar
• Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, et al. Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54:4314 - 20; http://dx.doi.org/10.1128/AAC.00185-10; PMID: 20660665
   PubMed Web of Science ®Google Scholar
• Leclercq R, Dutka-Malen S, Duval J, Courvalin P. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother 1992; 36:2005 - 8; PMID: 1416893
   PubMed Web of Science ®Google Scholar
• Navarro F, Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994; 38:1788 - 93; PMID: 7986009
   PubMed Web of Science ®Google Scholar
• Arias CA, Courvalin P, Reynolds PE. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 2000; 44:1660 - 6; http://dx.doi.org/10.1128/AAC.44.6.1660-1666.2000; PMID: 10817725
   PubMed Web of Science ®Google Scholar
• Guardabassi L, Christensen H, Hasman H, Dalsgaard A. Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococcal glycopeptide resistance genes vanA and vanB. Antimicrob Agents Chemother 2004; 48:4915 - 8; http://dx.doi.org/10.1128/AAC.48.12.4915-4918.2004; PMID: 15561881
   PubMed Web of Science ®Google Scholar
• Guardabassi L, Agersø Y. Genes homologous to glycopeptide resistance vanA are widespread in soil microbial communities. FEMS Microbiol Lett 2006; 259:221 - 5; http://dx.doi.org/10.1111/j.1574-6968.2006.00270.x; PMID: 16734783
   PubMed Web of Science ®Google Scholar
• Patel R, Piper K, Cockerill FR 3rd, Steckelberg JM, Yousten AA. The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster. Antimicrob Agents Chemother 2000; 44:705 - 9; http://dx.doi.org/10.1128/AAC.44.3.705-709.2000; PMID: 10681342
   PubMed Web of Science ®Google Scholar
• Stinear TP, Olden DC, Johnson PD, Davies JK, Grayson ML. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet 2001; 357:855 - 6; http://dx.doi.org/10.1016/S0140-6736(00)04206-9; PMID: 11265957
   PubMed Web of Science ®Google Scholar
• Tsvetkova K, Marvaud JC, Lambert T. Analysis of the mobilization functions of the vancomycin resistance transposon Tn1549, a member of a new family of conjugative elements. J Bacteriol 2010; 192:702 - 13; http://dx.doi.org/10.1128/JB.00680-09; PMID: 19966009
   PubMed Web of Science ®Google Scholar
• Galloway-Peña J, Roh JH, Latorre M, Qin X, Murray BE. Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium. PLoS One 2012; 7:e30187; http://dx.doi.org/10.1371/journal.pone.0030187; PMID: 22291916
   PubMedGoogle Scholar
• McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M, et al. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 2001; 345:1155 - 60; http://dx.doi.org/10.1056/NEJMoa010805; PMID: 11642231
   PubMed Web of Science ®Google Scholar
• Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, et al. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother 2004; 48:3583 - 5; http://dx.doi.org/10.1128/AAC.48.9.3583-3585.2004; PMID: 15328133
   PubMed Web of Science ®Google Scholar
• Hammerum AM, Flannagan SE, Clewell DB, Jensen LB. Indication of transposition of a mobile DNA element containing the vat(D) and erm(B) genes in Enterococcus faecium. Antimicrob Agents Chemother 2001; 45:3223 - 5; http://dx.doi.org/10.1128/AAC.45.11.3223-3225.2001; PMID: 11600385
   PubMed Web of Science ®Google Scholar
• Jensen LB, Hammerum AM, Aarestrup FM. Linkage of vat(E) and erm(B) in streptogamin-resistant Enterococcus faecium isolates from Europe. Antimicrob Agents Chemother 2000; 44:2231 - 2; http://dx.doi.org/10.1128/AAC.44.8.2231-2232.2000; PMID: 11023445
   PubMed Web of Science ®Google Scholar
• Jensen LB, Hammerum AM, Aerestrup FM, van den Bogaard AE, Stobberingh EE. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands. Antimicrob Agents Chemother 1998; 42:3330 - 1; PMID: 10049241
   PubMed Web of Science ®Google Scholar
• Bozdogan B, Leclercq R. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob Agents Chemother 1999; 43:2720 - 5; PMID: 10543753
   PubMed Web of Science ®Google Scholar
• Bozdogan B, Leclercq R, Lozniewski A, Weber M. Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032. Antimicrob Agents Chemother 1999; 43:2097 - 8; PMID: 10484759
   PubMed Web of Science ®Google Scholar
• Hershberger E, Donabedian S, Konstantinou K, Zervos MJ. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin Infect Dis 2004; 38:92 - 8; http://dx.doi.org/10.1086/380125; PMID: 14679454
   PubMed Web of Science ®Google Scholar
• Jung YH, Shin ES, Kim O, Yoo JS, Lee KM, Yoo JI, et al. Characterization of two newly identified genes, vgaD and vatH, [corrected] conferring resistance to streptogramin A in Enterococcus faecium. Antimicrob Agents Chemother 2010; 54:4744 - 9; http://dx.doi.org/10.1128/AAC.00798-09; PMID: 20713681
   PubMed Web of Science ®Google Scholar
• Meka VG, Gold HS. Antimicrobial resistance to linezolid. Clin Infect Dis 2004; 39:1010 - 5; http://dx.doi.org/10.1086/423841; PMID: 15472854
   PubMed Web of Science ®Google Scholar
• Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2007; 28:1382 - 8; http://dx.doi.org/10.1086/523276; PMID: 17994519
   PubMed Web of Science ®Google Scholar
• Lee ZM, Bussema C 3rd, Schmidt TM. rrnDB: documenting the number of rRNA and tRNA genes in bacteria and archaea. Nucleic Acids Res 2009; 37:Database issue D489 - 93; http://dx.doi.org/10.1093/nar/gkn689; PMID: 18948294
   PubMed Web of Science ®Google Scholar
• Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002; 46:3334 - 6; http://dx.doi.org/10.1128/AAC.46.10.3334-3336.2002; PMID: 12234875
   PubMed Web of Science ®Google Scholar
• Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008; 52:2244 - 6; http://dx.doi.org/10.1128/AAC.00231-08; PMID: 18391032
   PubMed Web of Science ®Google Scholar
• Bourgeois-Nicolaos N, Massias L, Couson B, Butel MJ, Andremont A, Doucet-Populaire F. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J Infect Dis 2007; 195:1480 - 8; http://dx.doi.org/10.1086/513876; PMID: 17436228
   PubMed Web of Science ®Google Scholar
• Biedenbach DJ, Farrell DJ, Mendes RE, Ross JE, Jones RN. Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program. Diagn Microbiol Infect Dis 2010; 68:459 - 67; http://dx.doi.org/10.1016/j.diagmicrobio.2010.09.018; PMID: 21094428
   PubMed Web of Science ®Google Scholar
• Prystowsky J, Siddiqui F, Chosay J, Shinabarger DL, Millichap J, Peterson LR, et al. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 2001; 45:2154 - 6; http://dx.doi.org/10.1128/AAC.45.7.2154-2156.2001; PMID: 11408243
   PubMed Web of Science ®Google Scholar
• Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B. The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrob Agents Chemother 2006; 50:2500 - 5; http://dx.doi.org/10.1128/AAC.00131-06; PMID: 16801432
   PubMed Web of Science ®Google Scholar
• Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K, Quinn J, et al. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 2007; 64:1506 - 14; http://dx.doi.org/10.1111/j.1365-2958.2007.05744.x; PMID: 17555436
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Wu C, Shen Z, Schwarz S, Du X, et al. First Report of the Multidrug Resistance gene cfr in Enterococcus faecalis of Animal origin. Antimicrob Agents Chemother 2012; 56:1650 - 4; http://dx.doi.org/10.1128/AAC.06091-11; PMID: 22203597
   PubMed Web of Science ®Google Scholar
• Cantón R, Ruiz-Garbajosa P, Chaves RL, Johnson AP. A potential role for daptomycin in enterococcal infections: what is the evidence?. J Antimicrob Chemother 2010; 65:1126 - 36; http://dx.doi.org/10.1093/jac/dkq087; PMID: 20363805
   PubMed Web of Science ®Google Scholar
• Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, et al. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Clin Ther 2010; 32:1713 - 9; http://dx.doi.org/10.1016/j.clinthera.2010.09.008; PMID: 21194593
   PubMed Web of Science ®Google Scholar
• Poutsiaka DD, Skiffington S, Miller KB, Hadley S, Snydman DR. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect 2007; 54:567 - 71; http://dx.doi.org/10.1016/j.jinf.2006.11.007; PMID: 17188750
   PubMed Web of Science ®Google Scholar
• Kelesidis T, Humphries R, Uslan DZ, Pegues DA. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 2011; 52:228 - 34; http://dx.doi.org/10.1093/cid/ciq113; PMID: 21288849
   PubMed Web of Science ®Google Scholar
• Lakey JH, Ptak M. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry 1988; 27:4639 - 45; http://dx.doi.org/10.1021/bi00413a009; PMID: 2844233
   PubMed Web of Science ®Google Scholar
• Alborn WE Jr., Allen NE, Preston DA. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother 1991; 35:2282 - 7; PMID: 1666494
   PubMed Web of Science ®Google Scholar
• Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:2538 - 44; http://dx.doi.org/10.1128/AAC.47.8.2538-2544.2003; PMID: 12878516
   PubMed Web of Science ®Google Scholar
• Silverman JA, Oliver N, Andrew T, Li T. Resistance studies with daptomycin. Antimicrob Agents Chemother 2001; 45:1799 - 802; http://dx.doi.org/10.1128/AAC.45.6.1799-1802.2001; PMID: 11353628
   PubMed Web of Science ®Google Scholar
• Friedman L, Alder JD, Silverman JA. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50:2137 - 45; http://dx.doi.org/10.1128/AAC.00039-06; PMID: 16723576
   PubMed Web of Science ®Google Scholar
• Palmer KL, Daniel A, Hardy C, Silverman J, Gilmore MS. Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother 2011; 55:3345 - 56; http://dx.doi.org/10.1128/AAC.00207-11; PMID: 21502617
   PubMedGoogle Scholar
• Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, et al. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 2011; 365:892 - 900; http://dx.doi.org/10.1056/NEJMoa1011138; PMID: 21899450
   PubMed Web of Science ®Google Scholar
• Cai Y, Wang R, Liang B, Bai N, Liu Y. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease. Antimicrob Agents Chemother 2011; 55:1162 - 72; http://dx.doi.org/10.1128/AAC.01402-10; PMID: 21173186
   PubMed Web of Science ®Google Scholar
• Kresken M, Leitner E, Seifert H, Peters G, von Eiff C. Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007). Eur J Clin Microbiol Infect Dis 2009; 28:1007 - 11; http://dx.doi.org/10.1007/s10096-009-0725-5; PMID: 19296137
   PubMed Web of Science ®Google Scholar
• Werner G, Gfrörer S, Fleige C, Witte W, Klare I. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 2008; 61:1182 - 3; http://dx.doi.org/10.1093/jac/dkn065; PMID: 18285315
   PubMed Web of Science ®Google Scholar
• Cordina C, Hill R, Deshpande A, Hood J, Inkster T. Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient. J Antimicrob Chemother 2012; 67:1806 - 7; http://dx.doi.org/10.1093/jac/dks122; PMID: 22454491
   PubMed Web of Science ®Google Scholar
• Tsai HY, Liao CH, Chen YH, Lu PL, Huang CH, Lu CT, et al. Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010. Antimicrob Agents Chemother 2012; 56:3402 - 5; http://dx.doi.org/10.1128/AAC.00533-12; PMID: 22491684
   PubMed Web of Science ®Google Scholar
• McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ, et al. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother 2005; 49:1865 - 71; http://dx.doi.org/10.1128/AAC.49.5.1865-1871.2005; PMID: 15855508
   PubMed Web of Science ®Google Scholar
• Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995; 21:1406 - 10; http://dx.doi.org/10.1093/clinids/21.6.1406; PMID: 8749624
   PubMed Web of Science ®Google Scholar
• Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, et al. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother 1996; 40:173 - 8; PMID: 8787901
   PubMed Web of Science ®Google Scholar
• Houlihan HH, Stokes DP, Rybak MJ. Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model. J Antimicrob Chemother 2000; 46:79 - 86; http://dx.doi.org/10.1093/jac/46.1.79; PMID: 10882693
   PubMed Web of Science ®Google Scholar
• López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, et al. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. Antimicrob Agents Chemother 2001; 45:1387 - 93; http://dx.doi.org/10.1128/AAC.45.5.1387-1393.2001; PMID: 11302800
   PubMed Web of Science ®Google Scholar
• Fantin B, Carbon C. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrob Agents Chemother 1990; 34:2387 - 91; PMID: 2128443
   PubMed Web of Science ®Google Scholar
• Marangos MN, Nicolau DP, Quintiliani R, Nightingale CH. Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis. J Antimicrob Chemother 1997; 39:519 - 22; http://dx.doi.org/10.1093/jac/39.4.519; PMID: 9145826
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Bolger AF, Levison ME, et al, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association, Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394 - 434; http://dx.doi.org/10.1161/CIRCULATIONAHA.105.165564; PMID: 15956145
   PubMed Web of Science ®Google Scholar
• Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W, et al. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2011; 55:4821 - 7; http://dx.doi.org/10.1128/AAC.00141-11; PMID: 21807979
   PubMed Web of Science ®Google Scholar
• Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, et al. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother 2003; 52:514 - 7; http://dx.doi.org/10.1093/jac/dkg360; PMID: 12917251
   PubMed Web of Science ®Google Scholar
• Miro JM, Cervera C, Garcia-de-la-Maria C, Del Rio A, Armero Y, Mestres CA, et al. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity. Scand J Infect Dis 2008; 40:968 - 72; http://dx.doi.org/10.1080/00365540802398945; PMID: 18767002
   PubMed Web of Science ®Google Scholar
• Euba G, Lora-Tamayo J, Murillo O, Pedrero S, Cabo J, Verdaguer R, et al. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis. Antimicrob Agents Chemother 2009; 53:4305 - 10; http://dx.doi.org/10.1128/AAC.00444-09; PMID: 19667290
   PubMed Web of Science ®Google Scholar
• Tascini C, Doria R, Leonildi A, Martinelli C, Menichetti F. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the “ex vivo” synergism method. J Chemother 2004; 16:400 - 3; PMID: 15332717
   PubMed Web of Science ®Google Scholar
• Farina C, Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, et al, Italian Infective Endocarditis Study Group (SEI). In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin. Chemotherapy 2011; 57:426 - 33; http://dx.doi.org/10.1159/000330458; PMID: 22122863
   PubMed Web of Science ®Google Scholar
• Brandt CM, Rouse MS, Laue NW, Stratton CW, Wilson WR, Steckelberg JM. Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis 1996; 173:909 - 13; http://dx.doi.org/10.1093/infdis/173.4.909; PMID: 8603970
   PubMed Web of Science ®Google Scholar
• Pasticci MB, Mencacci A, Moretti A, Palladino N, Maria Lapalorcia L, Bistoni F, et al. In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance. Open Microbiol J 2008; 2:79 - 84; http://dx.doi.org/10.2174/1874285800802010079; PMID: 19088915
   PubMedGoogle Scholar
• Moellering RC, Linden PK, Reinhardt J, Blumberg EA, Bompart F, Talbot GH, Synercid Emergency-Use Study Group. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1999; 44:251 - 61; http://dx.doi.org/10.1093/jac/44.2.251; PMID: 10473233
   PubMed Web of Science ®Google Scholar
• Chong YP, Lee SO, Song EH, Lee EJ, Jang EY, Kim SH, et al. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance. Scand J Infect Dis 2010; 42:491 - 9; http://dx.doi.org/10.3109/00365541003699623; PMID: 20524781
   PubMed Web of Science ®Google Scholar
• Bérenger R, Bourdon N, Auzou M, Leclercq R, Cattoir V. In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008. Med Mal Infect 2011; 41:405 - 9; http://dx.doi.org/10.1016/j.medmal.2010.12.013; PMID: 21550192
   PubMed Web of Science ®Google Scholar
• Arias CA, Torres HA, Singh KV, Panesso D, Moore J, Wanger A, et al. Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis 2007; 45:1343 - 6; http://dx.doi.org/10.1086/522656; PMID: 17968832
   PubMed Web of Science ®Google Scholar
• Baltch AL, Ritz WJ, Bopp LH, Michelsen PB, Smith RP. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51:1559 - 62; http://dx.doi.org/10.1128/AAC.00973-06; PMID: 17283190
   PubMed Web of Science ®Google Scholar
• Cilli F, Aydemir S, Tunger A. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci. J Chemother 2006; 18:27 - 32; PMID: 16572890
   PubMed Web of Science ®Google Scholar
• Snydman DR, McDermott LA, Jacobus NV. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves. J Chemother 2005; 17:614 - 21; PMID: 16433191
   PubMed Web of Science ®Google Scholar
• Pankey G, Ashcraft D, Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 2005; 49:5166 - 8; http://dx.doi.org/10.1128/AAC.49.12.5166-5168.2005; PMID: 16304195
   PubMed Web of Science ®Google Scholar
• Entenza JM, Moreillon P. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents 2009; 34:8 - , e1-9; http://dx.doi.org/10.1016/j.ijantimicag.2008.11.006; PMID: 19162449
   PubMed Web of Science ®Google Scholar
• Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Ge Y, Biek D, et al. In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin. Antimicrob Agents Chemother 2009; 53:5300 - 2; http://dx.doi.org/10.1128/AAC.00984-09; PMID: 19752276
   PubMed Web of Science ®Google Scholar
• Kak V, You I, Zervos MJ, Kariyama R, Kumon H, Chow JW. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2″)-Id gene. Diagn Microbiol Infect Dis 2000; 37:297 - 9; http://dx.doi.org/10.1016/S0732-8893(00)00155-3; PMID: 10974585
   PubMed Web of Science ®Google Scholar